Home LiteratureArticle Details
PMID: 2294058 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Infection and immunity ·Vol. 58 ·No. 1 ·1990-01-00 ·Pages 7-16

Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL

Abstract

Filamentous hemagglutinin (FHA) is a cell surface protein of Bordetella pertussis which functions as an adhesin for this organism. It is a component of many new acellular pertussis vaccines. The proposed role of FHA in immunity to pertussis is based on animal studies which have produced some conflicting results. To clarify this situation, we reexamined the protective activity of FHA in an adult mouse respiratory infection model. Four-week-old BALB/c mice were immunized with one or two doses of 4 or 8 micrograms of FHA and then aerosol challenged with B. pertussis Tohama I. In control mice receiving tetanus toxoid, the CFU in the lungs increased from 10(5) immediately following infection to greater than 10(6) by days 5 and 9 after challenge. Mice immunized with FHA by the intraperitoneal or intramuscular route had significantly reduced bacterial colonization in the lungs. A decrease in colonization of the trachea was also observed in FHA-immunized mice. Evaluation of antibody responses in these mice revealed high titers of immunoglobulin G (IgG) and IgM to FHA in sera and of IgG to FHA in lung lavage fluids. No IgA to FHA was detected. BALB/c mice were also passively immunized intravenously with either goat or rat antibodies to FHA and then aerosol challenged 24 h later, when anti-FHA antibodies were detected in the respiratory tract. Lung and tracheal colonization was markedly reduced in mice immunized with FHA-specific antibodies compared with those receiving control antibodies. In additional studies, the role of FHA in the colonization of the mouse respiratory tract was evaluated by using strain BP101, an FHA mutant of B. pertussis. FHA was important in the initial colonization of the mouse trachea, but was not required for colonization of the trachea later in the infection. FHA was not a factor in colonization of the lungs. Collectively, these experiments demonstrate (i) that systemic immunization with FHA can provide significant protection against B. pertussis infection in both the lower and upper respiratory tract of mice as defined by the lungs and trachea, respectively; (ii) that this protection is mediated primarily by serum antibodies to FHA, which transudate into respiratory secretions; and (iii) that FHA is an important upper respiratory tract colonization factor. These studies provide further evidence for the role of FHA in pertussis pathogenesis and immunity.

MeSH Terms
Animals Antibodies, Bacterial/biosynthesis Antigens, Bacterial/administration & dosage Bordetella pertussis/immunology Hemagglutinins/immunology Immunization Immunization, Passive Lung/microbiology Mice Mice, Inbred BALB C Pertussis Vaccine/immunology Trachea/microbiology Whooping Cough/microbiology,prevention & control
Chemicals
Antibodies, Bacterial Antigens, Bacterial Hemagglutinins Pertussis Vaccine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kimura A
Bacteriology Research Department, Praxis Biologics, Inc., Rochester, New York 14623.
Mountzouros K T
Relman D A
Falkow S
Cowell J L
References (37)
37 references, click to expand
  1. Identification of the predominant substrate for ADP-ribosylation by islet activating protein.
    J Biol Chem. 1983 Feb 25;258(4):2072-5 PMID: 6296122
  2. Scanning electron microscopy of mouse ciliated oviduct and tracheal epithelium infected in vitro with Bordetella pertussis.
    Can J Microbiol. 1983 Apr;29(4):415-20 PMID: 6850422
  3. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.
    Infect Immun. 1983 Jun;40(3):1198-203 PMID: 6682833
  4. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.
    J Biol Chem. 1983 Jun 10;258(11):6756-61 PMID: 6343381
  5. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Infect Immun. 1983 Jul;41(1):313-20 PMID: 6305841
  6. Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.
    Infect Immun. 1983 Sep;41(3):1138-43 PMID: 6309661
  7. Tn5-induced mutations affecting virulence factors of Bordetella pertussis.
    Infect Immun. 1983 Oct;42(1):33-41 PMID: 6311749
  8. Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies.
    J Gen Microbiol. 1983 Sep;129(9):2769-78 PMID: 6313862
  9. Development of a pertussis component vaccine in Japan.
    Lancet. 1984 Jan 21;1(8369):122-6 PMID: 6140441
  10. Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis.
    Infect Immun. 1984 Apr;44(1):1-6 PMID: 6608495
  11. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    J Infect Dis. 1984 Aug;150(2):219-22 PMID: 6088647
  12. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells.
    J Clin Microbiol. 1984 Aug;20(2):167-70 PMID: 6092416
  13. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system.
    Infect Immun. 1984 Nov;46(2):415-21 PMID: 6542069
  14. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
    J Infect Dis. 1984 Dec;150(6):823-33 PMID: 6094673
  15. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.
    Infect Immun. 1985 Feb;47(2):441-5 PMID: 2857154
  16. Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b.
    Infect Immun. 1985 May;48(2):343-9 PMID: 3872844
  17. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells.
    J Infect Dis. 1985 Jul;152(1):118-25 PMID: 2861240
  18. Protection against intranasal infection of mice with Bordetella pertussis.
    Dev Biol Stand. 1985;61:165-72 PMID: 2872102
  19. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.
    Dev Biol Stand. 1985;61:197-204 PMID: 2872105
  20. Virulence factors of Bordetella pertussis.
    Annu Rev Microbiol. 1986;40:661-86 PMID: 2877614
  21. Reflections on the efficacy of pertussis vaccines.
    Rev Infect Dis. 1987 Sep-Oct;9(5):866-83 PMID: 3317732
  22. Dissecting human T cell responses against Bordetella species.
    J Exp Med. 1988 Oct 1;168(4):1351-62 PMID: 2902185
  23. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence.
    Proc Natl Acad Sci U S A. 1989 Apr;86(8):2637-41 PMID: 2539596
  24. A simplification of the protein assay method of Lowry et al. which is more generally applicable.
    Anal Biochem. 1977 Dec;83(2):346-56 PMID: 603028
  25. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  26. Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties.
    Infect Immun. 1980 Mar;27(3):739-45 PMID: 6247278
  27. Aerosol infection of mice with Bordetella pertussis.
    Infect Immun. 1980 Jul;29(1):261-6 PMID: 6249758
  28. Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae.
    J Infect Dis. 1980 Oct;142(4):532-7 PMID: 6777436
  29. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Infect Immun. 1981 Mar;31(3):1223-31 PMID: 6262248
  30. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Infect Immun. 1981 Sep;33(3):820-6 PMID: 6269999
  31. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Anal Biochem. 1982 Jan 1;119(1):115-9 PMID: 6176137
  32. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.
    Proc Natl Acad Sci U S A. 1982 May;79(10):3129-33 PMID: 6954463
  33. Macrophage behaviour during the complaisant phase of murine pertussis.
    Immunology. 1969 Dec;17(6):875-87 PMID: 4318529
  34. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    J Gen Microbiol. 1972 Apr;70(2):371-82 PMID: 4338965
  35. Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.
    J Immunol. 1973 Aug;111(2):358-68 PMID: 4197982
  36. Improved techniques for the preparation of bacterial lipopolysaccharides.
    Can J Microbiol. 1976 Jan;22(1):29-34 PMID: 814982
  37. Expression of immune mechanisms in the lung.
    Am Rev Respir Dis. 1976 Mar;113(3):347-79 PMID: 769616
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1990-01-00
Pages
7-16
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC258400
Subset
IM
Grants
NIAID NIH HHS · AI23945 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com